September #84 : Run Interference - by Mike Barr

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join

Back to home » Archives » POZ Magazine issues

Table of Contents

This Face has a Message for the World

Lines Composed in a Looking Glass

The Problem with Protease

Lipo: The Latest

Parent Trap

What's Life Worth?


Wind Beneath Their Wings

Fuzzy Math:

Double Deal:

Getting Snippy

Creature Features

Clit Club


Safe Sucks:

Our Daily Med


Run Interference

Look, Ma, No KS!

Warts Up, Doc?

Thai Clip:

Only Connect:

False Alarm:

Tribute: Linda Grinberg

Bayou Blues




Back to Basics

Publisher's Letter

Most Popular Lessons

The HIV Life Cycle


Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

email print

September 2002

Run Interference

by Mike Barr

HIV's habit of invading your CD4 cells, commandeering the DNA to reproduce itself and then destroying the cells is what makes it such an annoying little critter, a.k.a. "an RNA-based retrovirus." Now researchers may have found a way to turn HIV's parasitic RNA against itself -- by using a new, engineered form of RNA that can trip up the delinquent retrovirus' breaking-and-entering act.

Phillip Sharp, MD, a Massachusetts Institute of Technology virologist who won the Nobel in 1993 for related work, has turned his attention to the possibility of using these "interfering RNAs" against HIV and other viral infections.

In lab studies with mouse cells, two interfering RNAs -- one designed to target CD4s, the other to target the HIV core protein p24 -- were both shown to disable HIV's infection system. Tests to aim at a third target, CCR5, a cell protein that functions as an HIV receptor, are also planned.

The interfering-RNA approach is similar to previous attempts at gene therapy -- they all seek to switch off, or bind to, specific genes necessary for viral production and proliferation. One such technique, "antisense" technology, burst onto the scene with great fanfare in the late '80s. But as with nearly all such gene machines, the main mystery with both antisense and interfering RNA remains how to coax the stuff into the desired cells in the body, a not-so-simple trick techies call "drug delivery."

Harvard's Judy Lieberman, MD, Sharp's collaborator, struck an optimistic note. If these successes in the lab can be repeated in live animals, she said, she'll be optimistic about one day using interfering RNAs to stop HIV replication in humans.

If this all sounds very future shock, it is. "There are many obstacles to surmount before this could be a basis for treatment," Sharp said, cautioning that an RNA-based med would be "several years off, at least." Meantime, triple cocktails will have to do.

[Go to top]

Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Did you participate in an event for National Black HIV/AIDS Awareness Day 2016?


more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2016 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.